Latest news
Recovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA - medcitynews.commedcitynews.com · Fri, 07 Aug 2026 22:12:34 GMTTudriqev: US FDA Approves Replimune's Skin Cancer Drug After Rejecting It Twice - Health and MeHealth and Me · Fri, 07 Aug 2026 12:34:03 GMTFDA Approves Twice-Rejected Oncolytic Virus Combination for Melanoma - Oncology News CentralOncology News Central · Fri, 07 Aug 2026 10:27:13 GMTFDA Finally OKs Twice-Rejected Melanoma Drug - MedPage TodayMedPage Today · Thu, 06 Aug 2026 21:40:02 GMTFDA approves Replimune melanoma drug previously rejected twice - STATSTAT · Thu, 06 Aug 2026 20:04:45 GMTReplimune melanoma drug snags coveted FDA approval after yearlong clash, two rejections - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 20:03:00 GMTTwice-Rejected Advanced Melanoma Treatment Wins FDA Committee Vote - Oncology News CentralOncology News Central · Fri, 31 Jul 2026 07:00:00 GMTReplimune’s twice-rejected melanoma drug prevails in FDA adcomm - Fierce BiotechFierce Biotech · Thu, 30 Jul 2026 22:20:27 GMT